Details for New Drug Application (NDA): 013422
✉ Email this page to a colleague
The generic ingredient in MAXIDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 013422
Tradename: | MAXIDEX |
Applicant: | Harrow Eye |
Ingredient: | dexamethasone |
Patents: | 0 |
Pharmacology for NDA: 013422
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 013422
Suppliers and Packaging for NDA: 013422
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MAXIDEX | dexamethasone | SUSPENSION/DROPS;OPHTHALMIC | 013422 | NDA | Novartis Pharmaceuticals Corporation | 0078-0925 | 0078-0925-25 | 5 mL in 1 BOTTLE (0078-0925-25) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION/DROPS;OPHTHALMIC | Strength | 0.1% | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Complete Access Available with Subscription